Your browser doesn't support javascript.
loading
Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome.
Chien, Kelly S; Kim, Kunhwa; Nogueras-Gonzalez, Graciela M; Borthakur, Gautam; Naqvi, Kiran; Daver, Naval G; Montalban-Bravo, Guillermo; Cortes, Jorge E; DiNardo, Courtney D; Jabbour, Elias; Alvarado, Yesid; Andreeff, Michael; Bose, Prithviraj; Jain, Nitin; Kadia, Tapan M; Huang, Xuelin; Sheppard, Kimberly B; Klingner-Winton, Cheri; Pierce, Sherry A; Dong, Xiao Qin; Soltysiak, Kelly A; Kantarjian, Hagop M; Garcia-Manero, Guillermo.
Afiliação
  • Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kim K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nogueras-Gonzalez GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Naqvi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cortes JE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sheppard KB; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Klingner-Winton C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pierce SA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Dong XQ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Br J Haematol ; 195(3): 378-387, 2021 11.
Article em En | MEDLINE | ID: mdl-34340254
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Anticorpos Monoclonais Humanizados / Antimetabólitos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Anticorpos Monoclonais Humanizados / Antimetabólitos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos